Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients

The Egyptian Journal of Internal Medicine volume 30, pages 18–22 (2018)Cite this article

Abstract

Background

Vaspin is a compensatory adipokine with anti-inflammatory properties that can improve insulin sensitivity and plays a cardioprotective role.

Aim

The aim of this study was to evaluate the level of vaspin in patients with end-stage renal disease on hemodialysis (HD) and to determine whether it has any relation to the presence of ischemic heart disease (IHD) in these patients.

Patients and methods

The study was carried out on 45 HD patients who were divided into 15 patients with risk factors of developing IHD (group I) and 30 patients (group II) proved to have IHD by echocardiography and ECG compared with 20 healthy individuals (group III).

Results

We found that the mean±SD of serum vaspin was significantly lower in HD patients with IHD (0.57±0.27) ng/ml compared with the control group (0.74±0.20) ng/ml and there was a negative correlation between serum vaspin and serum creatinine in group I and group II. Also, an receiver operating characteristics study for patients with IHD (group II) yielded a vaspin cut-off value of 0.410 ng/ml with a sensitivity of 40%, a specificity of 100%, a positive predictive value of 100%, and an negative predictive value of 53%, whereas the cut-off value for serum vaspin was 0.485 ng/ ml in patients at risk of developing IHD, with a sensitivity of 100%, a specificity of 85%, a positive predictive value of 83%, and an negative predictive value of 100%.

Conclusion

Lower vaspin level is associated independently with IHD in HD patients and can be used as a predictor of IHD in patients with end-stage renal disease.

References

  1. Hou F, Jiang J, Chen J, Yu X, Zhou Q, Chen P, et al. China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. BMC Nephrol 2012; 13:94.

    Article  Google Scholar 

  2. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005; 102:10610–10615.

    Article  CAS  Google Scholar 

  3. Phalitakul S, Okada M, Hara Y, Yamawaki H. Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappa B and PKC theta activation in cultured rat vascular smooth muscle cells. Pharmacol Res 2011; 64:493–500.

    Article  CAS  Google Scholar 

  4. Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL, Park JY. Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun 2011; 413:264–269.

    Article  CAS  Google Scholar 

  5. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J. Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer 2010; 127:2159–2168.

    Article  CAS  Google Scholar 

  6. Inoue J, Wada J, Teshigawara S, Hida K, Nakatsuka A, Takatori Y, et al. The serum vaspin levels are reduced in Japanese chronic hemodialysis patients. BMC Nephrol 2012; 313:163.

    Article  Google Scholar 

  7. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 5: 372–377.

    Article  Google Scholar 

  8. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, The of ilogiannakos EK, Kottas G, Lampropoulos S. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta 2011; 412: 48–52.

    Article  CAS  Google Scholar 

  9. Li HL, Peng WH, Cui ST, Lei H, Wei YD, Li WM, Xu YW. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011; 49:1547–1554.

    CAS  PubMed  Google Scholar 

  10. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, et al. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 2011; 75:628–635.

    Article  CAS  Google Scholar 

  11. Lin Y, Zhuang J, Li H, Zhu G, Zhou S, Li W, et al. Vaspin attenuates the progression of atherosclerosis by inhibiting ER stress-induced macrophage apoptosis in apoE-/- mice. Mol Med Rep 2016; 13:1509–1516.

    Article  CAS  Google Scholar 

  12. Seeger J, Ziegelmeier M, Bachmann A,Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008; 93:247–251.

    Article  CAS  Google Scholar 

  13. Yan M, Su B, Peng W, Li L, Li H, Zhuang J, et al. Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus. J Diabetes Res 2014; 2014:868732.

    Google Scholar 

  14. Kobat MA, Celik A, Balin M, Altas Y, Baydas A, Bulut M, et al. The investigation of serum vaspin level in atherosclerotic coronary artery disease. J Clin Med Res 2012; 4:110–113.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Su Y, Ming Q, Li W, Peng W, Li H, Xu Y. Serum vaspin: a reliable independent predictor for major adverse cardiac events. Int J Clin Exp Med 2016; 9:18133–18141.

    CAS  Google Scholar 

  16. Tasnim F, Phil M, Omar Faruque M, Hassan Z, Ali L. Serum vaspin levels are associated with decreased insulin sensitivity in newly diagnosed type 2 diabetes mellitus in Bangladesh. J Taibah Univ Med Sci 2015; 10:327–332.

    Google Scholar 

  17. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 2011; 12:60.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine for Girls Al-Azhar University, Cairo, Egypt

    Hayam H. Mansour, Amal H. Ibrahim & Sherif A. Nassib

  2. Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt

    Nagwa A. Mohamed

  3. Department of Internal Medicine, Aswan University, Aswan, Egypt

    Omaima M. Ali

Authors
  1. Hayam H. Mansour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amal H. Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nagwa A. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Omaima M. Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sherif A. Nassib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hayam H. Mansour.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mansour, H.H., Ibrahim, A.H., Mohamed, N.A. et al. Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients. Egypt J Intern Med 30, 18–22 (2018). https://doi.org/10.4103/ejim.ejim_55_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_55_17

Keywords